Your session is about to expire
What is Zemplar
Approved as Treatment by the FDA
Paricalcitol, also known as Zemplar, is approved by the FDA for 8 uses which include Hyperparathyroidism, Secondary and Hyperparathyroidism, Secondary .Effectiveness
When to interrupt dosage
The recommended measure of Zemplar depends on the diagnosed condition, including Hyperparathyroidism, Secondary, Hemodialysis and Stage 4 Chronic Kidney Disease. The dosage can be found in the table below, contingent upon the technique of administration.Warnings
There are 20 known major drug interactions with Zemplar.Zemplar Novel Uses: Which Conditions Have a Clinical Trial Featuring Zemplar?
15 active trials are currently evaluating the potential of Zemplar in alleviating Stage 4 Chronic Kidney Disease, Chronic Kidney Disease, Stage 3 (Moderate) and Hemodialysis.Zemplar Reviews: What are patients saying about Zemplar?
Patient Q&A Section about zemplar
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What class of drug is ZEMPLAR?
"The safety and effectiveness of Zemplar have not been established in children younger than 5 years of age (IV dosing) and 10 years of age (orally)."
What is ZEMPLAR used for?
"ZEMPLAR is a type of vitamin d that is used to prevent and treat secondary hyperparathyroidism. This condition is characterized by an increase in parathyroid hormone levels. ZEMPLAR is approved for use in adults and children who are 10 years of age or older and have Stage 3 or Stage 4 chronic kidney disease, or who are in Stage 5 of renal failure and are receiving dialysis."
When do you give ZEMPLAR?
"ZEMPLAR should be administered three times per week, no more frequently than every other day, at any time during dialysis. The maintenance dose of ZEMPLAR should be targeted to intact PTH levels within the desired therapeutic range and serum calcium within normal limits."